Technologie BiolActis

About Technologie BiolActis

Technologie BiolActis is a Canadian biotechnology firm situated in Saguenay, Quebec, that concentrates on the development of 'lactoceuticals'.

The company's scientific efforts are directed towards creating products aimed at addressing cardiovascular diseases, metabolic-related conditions, and disorders associated with obesity. This positions BiolActis within the nutraceutical and biotech sectors, focusing on health solutions derived from milk-based compounds. The term 'lactoceuticals' suggests a specialization in therapeutic or health-promoting agents originating from lactic acid bacteria or milk components, a field that leverages the growing consumer interest in probiotics and gut health for managing systemic health issues.

In a significant financial milestone, Technologie BiolActis secured a Series A financing round in February 2006, raising $7.3 million CAD. The round, which included a provision for an additional $1.4 million in follow-on capital, was led by Inventages Venture Capital Investments Inc. Concurrent with this funding, the company restructured its balance sheet by converting $1.9 million in long-term liabilities from backers including Investissement Québec, Amisk, and CQVB into equity, consolidating its financial base for future research and development. The business model likely revolves around research and development, potentially leading to licensing agreements, partnerships with larger pharmaceutical or food companies, or the creation of proprietary branded products for the health and wellness market.